The heterogeneity in ventricular arrhythmias shouldn’t be overlooked when planning chronic management for a given patient and deciding whether an implantable cardioverter-defibrillator (ICD), antiarrhythmic drug, or catheter ablation would be appropriate therapies.
In this episode of the AP Cardiology podcast, Andrew Perry, MD, speaks with Melissa Robinson, MD, of University of Washington, Seattle, about three cases that illustrate why there is no one-size-fits-all approach to ventricular tachycardia.
A transcript of the podcast follows:
Perry: Hi everyone, Andrew here. For this episode, I have a fantastic educator visiting. Dr. Melissa Robinson is a star faculty at the University of Washington in the electrophysiology section. She focuses on complex ablations. She is the go-to person for complicated…